P. Heron et S. Daya, 17 beta-estradiol protects against quinolinic acid-induced lipid peroxidation in the rat brain, METAB BRAIN, 15(4), 2000, pp. 267-274
The neurotoxin quinolinic acid has been identified as a causative agent in
Huntington's disease and is a metabolite of the tryptophan pathway in the b
rain. In the present study, the in vivo and in vitro effect of 17 beta -est
radiol on lipid peroxidation induced by quinolinic acid was investigated. F
or the in vivo experiments ovariectomized female rats were administered wit
h 100 mug 17 beta -estradiol daily for seven days prior to and seven days f
ollowing the intrahippocampal injection of 1 mu mol quinolinic acid. The le
vel of lipid peroxidation in brain homogenate was investigated using the th
iobarbituric acid test. The in vitro experiments were performed in brain ho
mogenates of ovariectomized female rats. The homogenate was treated with qu
inolinic acid alone or in combination with 17 beta -estradiol. Quinolinic a
cid increased lipid peroxidation in a dose dependent manner in vitro, while
homogenate co-treated with 17 beta -estradiol showed a significant reducti
on in lipid peroxidation. 17 beta -estradiol was also shown to be protectiv
e against quinolinic acid in vivo. These results could explain the neuropro
tective effect of 17 beta -estradiol.